600645.SS
600645.SS
CNE000000545
VCANBIO CELL & GENE ENG CORP LT
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
8.94B EUR
8.01B EUR
14.46B EUR
11.79B EUR
Enterprise Value
7B EUR
6.79B EUR
12.95B EUR
10.85B EUR
Valuation Multiples
Trailing P/E
76.4x
119.55x
241.36x
185.14x
Forward P/E
43.41x
--
--
--
Price to Sales
6.39x
7.84x
13.83x
10.93x
Price to Book
2.33x
2.14x
3.89x
3.18x
EV/Revenue
5.01x
6.65x
12.39x
10.06x
EV/EBITDA
29.93x
47x
83.97x
68.42x
Price to FCF (P/FCF)
41.12x
41.75x
89.26x
66.43x
EV/FCF
32.21x
35.41x
79.94x
61.14x
FCF Yield
2.43%
2.4%
1.12%
1.51%
ende